Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Scientists unearth new molecular targets on AT1R that could lead to improved drugs for heart disease

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

It’s a good news week: the FDA has approved the first cell therapy to treat unresectable or metastatic melanoma

Do you think PRINT will stand the test of time – or will better options supersede its development?